
### [NCIT:C3283](http://purl.obolibrary.org/obo/NCIT_C3283)
**Label:** Obesity

**Corr. equiv. classes:** [http://purl.obolibrary.org/obo/NCIT_C24689](NCIT:C24689) (PPARG Gene), [http://purl.obolibrary.org/obo/NCIT_C20577](NCIT:C20577) (HMGA2 Gene), 605e6d93-839c-4faa-a07c-cc8ef78ccb4738c89697-e505-40f5-8732-a15961b28f2f[http://purl.obolibrary.org/obo/NCIT_C3013](NCIT:C3013) (Endometrial Hyperplasia), 

**Class expressions from DL-Learner:**

- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([NCIT:C8356](http://purl.obolibrary.org/obo/NCIT_C8356) (Atypical Glandular Hyperplasia))) 52.02%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([NCIT:C8355](http://purl.obolibrary.org/obo/NCIT_C8355) (Atypical Hyperplasia))) 52.02%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([NCIT:C8278](http://purl.obolibrary.org/obo/NCIT_C8278) (Cancer-Related Condition))) 52.02%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([NCIT:C7422](http://purl.obolibrary.org/obo/NCIT_C7422) (Precancerous Condition by Site))) 52.02%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([NCIT:C4654](http://purl.obolibrary.org/obo/NCIT_C4654) (Atypical Endometrial Hyperplasia))) 52.02%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([NCIT:C3341](http://purl.obolibrary.org/obo/NCIT_C3341) (Precancerous Condition))) 52.02%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([NCIT:C27788](http://purl.obolibrary.org/obo/NCIT_C27788) (Female Reproductive System Precancerous Condition))) 52.02%
- Thing 50.70%
- [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia) 45.53%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) 45.53%
- [NCIT:C4875](http://purl.obolibrary.org/obo/NCIT_C4875) (Reproductive System Disorder) and [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia) 45.53%
- [NCIT:C3504](http://purl.obolibrary.org/obo/NCIT_C3504) (Endometrial Disorder) and [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia) 45.53%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) and [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia) 45.53%
- [NCIT:C27020](http://purl.obolibrary.org/obo/NCIT_C27020) (Female Reproductive System Disorder) and [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia) 45.53%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia) 45.53%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([CHEBI:16541](http://purl.obolibrary.org/obo/CHEBI_16541) (protein polypeptide chain))) 45.53%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([CHEBI:16336](http://purl.obolibrary.org/obo/CHEBI_16336) (hyaluronic acid))) 45.53%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([CHEBI:15440](http://purl.obolibrary.org/obo/CHEBI_15440) (squalene))) 45.53%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not ([CHEBI:10545](http://purl.obolibrary.org/obo/CHEBI_10545) (electron))) 45.53%
- [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia) and (not (CARO:0010000)) 45.53%


